Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Genzyme Corp.

, Cambridge, Mass.

Joseph Edelman of Prudential Securities upgraded Genzyme Corp. (Cambridge, Mass.) to "buy" from "hold" with a 12-month

Read the full 210 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE